Cambridge Healthtech Institute’s 16th Annual

Target Identification and Validation  

Leveraging Functional Genomics, Phenotypic and Computational Screening

September 17-18, 2019


Finding novel, druggable targets for therapeutic intervention remains a top priority for the pharma/biotech industry. It also remains a formidable challenge and companies continue to invest a lot of time and resources in identifying and validating targets that will yield viable drugs. What are the challenges in target discovery today? What new tools and strategies are being used to identify targets and how well are they working? What’s being done to adequately validate the targets once they are identified? What efforts are being taken to go after difficult or “undruggable” targets? Cambridge Healthtech Institute’s conference on Target Identification and Validation will bring together leading experts to discuss some of these critical issues. This is an unique opportunity to meet and network with biologists and screening groups from around the world to share ideas and set up collaborations.


Who should attend: Scientists and Executives from Pharma, Biotech, Academia, Government, Contract Research Labs and Technology Providers involved in Target Identification & Validation, Discovery Biology, Biochemistry, Molecular & Cell Biology, High-Throughput Screening, Phenotypic Screening, Functional Genomics, Chemical Biology, Computational Biology, Bioinformatics, and other areas related to early drug discovery & development.


Coverage will include, but is not limited to:

  • Use of CRISPR, RNAi, and chemical genomic screens for finding novel targets
  • Exploring various models, assays and platforms for phenotypic screening
  • Effectively using PROTACs and molecular glues for target degradation and deconvolution
  • Chemoproteomic profiling for target identification and mechanism-of-action studies
  • Exploring artificial intelligence and machine learning tools for target identification and characterization
  • Using databases and data visualization tools for associating targets and diseases
  • Case studies on how to deconvolute and prioritize druggable targets from screening hits  
  • Complementary use of technologies for target deconvolution and validation     


If you would like to submit a proposal to give a presentation at this meeting, please click here.


The deadline for priority consideration is February 27, 2019.


All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.


For more details on the conference, please contact:
Tanuja Koppal, PhD

Conference Director

Cambridge Healthtech Institute



For partnering and sponsorship information, please contact:
Rod Eymael

Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-6286

Premier Sponsors

Ablexis Alivamab_stacked



OmniAb Ligand_Pharmaceuticals